Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

National Institute of Allergy and Infectious Diseases (NIAID) · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
immune-response
epstein-barr virus infection, infectious mononucleosis, herpesvirus, neutralizing antibody, immune response, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 826321
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.